Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001415889-18-000188

Options or other derivatives

  • CHIEF MEDICAL OFFICER acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Smith Mark Alan CHIEF MEDICAL OFFICER 2018-02-02 Grant or award · Stock Option (Right to Buy) +200,000 200,000 D
Loading xslF345X03/form4-02052018_010240.xml…